You can buy or sell SURF and other stocks, options, ETFs, and crypto commission-free!
Surface Oncology, Inc. Common Stock, also called Surface Oncology, is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. Read More The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Simply Wall StFeb 20
How Many Surface Oncology, Inc. (NASDAQ:SURF) Shares Do Institutions Own?
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! A look at the shareholders of Surface Oncology, Inc. (NASDAQ:SURF) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. Companies that used to be publicly owned tend to have lower insider ownership. Surface Oncology is a smaller company with a market capitaliza...
Expected May 28, After Hours